Literature DB >> 33094644

BRD4 (Bromodomain-Containing Protein 4) Interacts with GATA4 (GATA Binding Protein 4) to Govern Mitochondrial Homeostasis in Adult Cardiomyocytes.

Arun Padmanabhan1,2, Michael Alexanian1, Ricardo Linares-Saldana3, Rajan Jain3, Deepak Srivastava1,4,5,6, Bárbara González-Terán1, Gaia Andreoletti7, Yu Huang1, Andrew J Connolly8, Wonho Kim3, Austin Hsu1, Qiming Duan1, Sarah A B Winchester1, Franco Felix1, Juan A Perez-Bermejo1, Qiaohong Wang3, Li Li3, Parisha P Shah3, Saptarsi M Haldar1,2.   

Abstract

BACKGROUND: Gene regulatory networks control tissue homeostasis and disease progression in a cell type-specific manner. Ubiquitously expressed chromatin regulators modulate these networks, yet the mechanisms governing how tissue specificity of their function is achieved are poorly understood. BRD4 (bromodomain-containing protein 4), a member of the BET (bromo- and extraterminal domain) family of ubiquitously expressed acetyl-lysine reader proteins, plays a pivotal role as a coactivator of enhancer signaling across diverse tissue types in both health and disease and has been implicated as a pharmacological target in heart failure. However, the cell-specific role of BRD4 in adult cardiomyocytes remains unknown.
METHODS: We combined conditional mouse genetics, unbiased transcriptomic and epigenomic analyses, and classic molecular biology and biochemical approaches to understand the mechanism by which BRD4 in adult cardiomyocyte homeostasis.
RESULTS: Here, we show that cardiomyocyte-specific deletion of Brd4 in adult mice leads to acute deterioration of cardiac contractile function with mutant animals demonstrating a transcriptomic signature characterized by decreased expression of genes critical for mitochondrial energy production. Genome-wide occupancy data show that BRD4 enriches at many downregulated genes (including the master coactivators Ppargc1a, Ppargc1b, and their downstream targets) and preferentially colocalizes with GATA4 (GATA binding protein 4), a lineage-determining cardiac transcription factor not previously implicated in regulation of adult cardiac metabolism. BRD4 and GATA4 form an endogenous complex in cardiomyocytes and interact in a bromodomain-independent manner, revealing a new functional interaction partner for BRD4 that can direct its locus and tissue specificity.
CONCLUSIONS: These results highlight a novel role for a BRD4-GATA4 module in cooperative regulation of a cardiomyocyte-specific gene program governing bioenergetic homeostasis in the adult heart.

Entities:  

Keywords:  epigenomics; mitochondria; myocytes, cardiac

Mesh:

Substances:

Year:  2020        PMID: 33094644      PMCID: PMC7736290          DOI: 10.1161/CIRCULATIONAHA.120.047753

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  80 in total

1.  Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.

Authors:  Zhiyuan Yang; Jasper H N Yik; Ruichuan Chen; Nanhai He; Moon Kyoo Jang; Keiko Ozato; Qiang Zhou
Journal:  Mol Cell       Date:  2005-08-19       Impact factor: 17.970

2.  First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors.

Authors:  Sarina A Piha-Paul; Jasgit C Sachdev; Minal Barve; Patricia LoRusso; Russell Szmulewitz; Sapna Pradyuman Patel; Primo N Lara; Xiaotian Chen; Beibei Hu; Kevin J Freise; Dimple Modi; Anjla Sood; Jessica E Hutti; Johannes Wolff; Bert H O'Neil
Journal:  Clin Cancer Res       Date:  2019-08-16       Impact factor: 12.531

3.  DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation.

Authors:  Georg E Winter; Dennis L Buckley; Joshiawa Paulk; Justin M Roberts; Amanda Souza; Sirano Dhe-Paganon; James E Bradner
Journal:  Science       Date:  2015-05-21       Impact factor: 47.728

Review 4.  The mechanisms behind the therapeutic activity of BET bromodomain inhibition.

Authors:  Junwei Shi; Christopher R Vakoc
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

5.  The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.

Authors:  Shaila Rahman; Mathew E Sowa; Matthias Ottinger; Jennifer A Smith; Yang Shi; J Wade Harper; Peter M Howley
Journal:  Mol Cell Biol       Date:  2011-05-09       Impact factor: 4.272

6.  Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle.

Authors:  Zoltan Arany; Huamei He; Jiandie Lin; Kirsten Hoyer; Christoph Handschin; Okan Toka; Ferhaan Ahmad; Takashi Matsui; Sherry Chin; Pei-Hsuan Wu; Igor I Rybkin; John M Shelton; Monia Manieri; Saverio Cinti; Frederick J Schoen; Rhonda Bassel-Duby; Anthony Rosenzweig; Joanne S Ingwall; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-04       Impact factor: 27.287

7.  BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia.

Authors:  Jae-Seok Roe; Fatih Mercan; Keith Rivera; Darryl J Pappin; Christopher R Vakoc
Journal:  Mol Cell       Date:  2015-05-14       Impact factor: 17.970

8.  A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription.

Authors:  C Grépin; L Dagnino; L Robitaille; L Haberstroh; T Antakly; M Nemer
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

9.  Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models.

Authors:  Norimichi Koitabashi; Djahida Bedja; Ari L Zaiman; Yigal M Pinto; Manling Zhang; Kathleen L Gabrielson; Eiki Takimoto; David A Kass
Journal:  Circ Res       Date:  2009-06-11       Impact factor: 17.367

10.  European Society of Cardiology: Cardiovascular Disease Statistics 2019.

Authors:  Adam Timmis; Nick Townsend; Chris P Gale; Aleksandra Torbica; Maddalena Lettino; Steffen E Petersen; Elias A Mossialos; Aldo P Maggioni; Dzianis Kazakiewicz; Heidi T May; Delphine De Smedt; Marcus Flather; Liesl Zuhlke; John F Beltrame; Radu Huculeci; Luigi Tavazzi; Gerhard Hindricks; Jeroen Bax; Barbara Casadei; Stephan Achenbach; Lucy Wright; Panos Vardas
Journal:  Eur Heart J       Date:  2020-01-01       Impact factor: 29.983

View more
  12 in total

1.  BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression.

Authors:  Qiong Wu; Fangfang Liu; Mengmeng Ge; Kyle Vaughn Laster; Lixiao Wei; Ruijuan Du; Ming Jiang; Jing Zhang; Yafei Zhi; Guoguo Jin; Simin Zhao; Dong Joon Kim; Zigang Dong; Kangdong Liu
Journal:  Oncogene       Date:  2021-11-08       Impact factor: 9.867

2.  BRD4 orchestrates genome folding to promote neural crest differentiation.

Authors:  Ricardo Linares-Saldana; Wonho Kim; Nikhita A Bolar; Haoyue Zhang; Bailey A Koch-Bojalad; Sora Yoon; Parisha P Shah; Ashley Karnay; Daniel S Park; Jennifer M Luppino; Son C Nguyen; Arun Padmanabhan; Cheryl L Smith; Andrey Poleshko; Qiaohong Wang; Li Li; Deepak Srivastava; Golnaz Vahedi; Gwang Hyeon Eom; Gerd A Blobel; Eric F Joyce; Rajan Jain
Journal:  Nat Genet       Date:  2021-10-05       Impact factor: 38.330

3.  Histone Deacetylase 6 Inhibitor JS28 Prevents Pathological Gene Expression in Cardiac Myocytes.

Authors:  Vivien Ngo; Bernd K Fleischmann; Manfred Jung; Lutz Hein; Achim Lother
Journal:  J Am Heart Assoc       Date:  2022-06-14       Impact factor: 6.106

4.  Transcription factor protein interactomes reveal genetic determinants in heart disease.

Authors:  Barbara Gonzalez-Teran; Maureen Pittman; Franco Felix; Reuben Thomas; Desmond Richmond-Buccola; Ruth Hüttenhain; Krishna Choudhary; Elisabetta Moroni; Mauro W Costa; Yu Huang; Arun Padmanabhan; Michael Alexanian; Clara Youngna Lee; Bonnie E J Maven; Kaitlen Samse-Knapp; Sarah U Morton; Michael McGregor; Casey A Gifford; J G Seidman; Christine E Seidman; Bruce D Gelb; Giorgio Colombo; Bruce R Conklin; Brian L Black; Benoit G Bruneau; Nevan J Krogan; Katherine S Pollard; Deepak Srivastava
Journal:  Cell       Date:  2022-02-18       Impact factor: 66.850

5.  Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.

Authors:  Pan Tang; Jifa Zhang; Jie Liu; Cheng-Ming Chiang; Liang Ouyang
Journal:  J Med Chem       Date:  2021-02-22       Impact factor: 7.446

Review 6.  The role of metabolism in directed differentiation versus trans-differentiation of cardiomyocytes.

Authors:  James W S Jahng; Mao Zhang; Joseph C Wu
Journal:  Semin Cell Dev Biol       Date:  2021-05-29       Impact factor: 7.727

Review 7.  Mitochondria and metabolic transitions in cardiomyocytes: lessons from development for stem cell-derived cardiomyocytes.

Authors:  Jessica C Garbern; Richard T Lee
Journal:  Stem Cell Res Ther       Date:  2021-03-12       Impact factor: 6.832

8.  Epigenetics of Mitochondria-Associated Genes in Striated Muscle.

Authors:  Kenneth C Ehrlich; Hong-Wen Deng; Melanie Ehrlich
Journal:  Epigenomes       Date:  2021-12-22

Review 9.  The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy.

Authors:  Siarhei A Dabravolski; Nikolay K Sadykhov; Andrey G Kartuesov; Evgeny E Borisov; Vasily N Sukhorukov; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

Review 10.  BET Protein-Mediated Transcriptional Regulation in Heart Failure.

Authors:  Talha Ijaz; Michael A Burke
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.